Evaluation of coronary risk score applications in 10-year coronary heart risk estimation
Atherosclerosis is a multifactorial disease with risk factors that have multiple effects. In the identification and treatment of asymptomatic individuals at high risk for developing coronary heart disease (CHD) different risk scoring schemes are used in everyday routine. The aim of this study was to...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Medical Biochemists of Serbia, Belgrade
2009-01-01
|
| Series: | Journal of Medical Biochemistry |
| Subjects: | |
| Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2009/1452-82580903145E.pdf |
| _version_ | 1818215913243017216 |
|---|---|
| author | Eremić Nevena Đerić Mirjana |
| author_facet | Eremić Nevena Đerić Mirjana |
| author_sort | Eremić Nevena |
| collection | DOAJ |
| description | Atherosclerosis is a multifactorial disease with risk factors that have multiple effects. In the identification and treatment of asymptomatic individuals at high risk for developing coronary heart disease (CHD) different risk scoring schemes are used in everyday routine. The aim of this study was to compare SCORE recommended for our country with two other most frequently used risk schemes for 10-year CHD risk evaluation: Framingham and PROCAM as well as their modifications. From 220 examined subjects of both sexes, who were treated mainly for lipid metabolism disorder at the Dispensary for Atherosclerosis Prevention, Center for Laboratory Medicine, Clinical Center of Vojvodina, 110 subjects were included in our study and agreed to a one-year follow-up. At first check-up, 15% had low risk according to Framingham Weibull and 78% according to PROCAM, intermediate 12% according to PROCAM NS up to 45% according to Framingham Weibull, and high 8% according to PROCAM up to 40% according to Framingham Weibull. After a one-year treatment 30% were in the low risk category according to Framingham Weibull and 88% according to PROCAM. Intermediate from 10% according to PROCAM to 36% according to Framingham Weibull, and high from 2% according to PROCAM to 25% according to Framingham Weibull. There is a significantly lower percentage of high risk individuals and a higher percentage of low risk individuals after one year of lipid disorder treatment. |
| first_indexed | 2024-12-12T06:43:38Z |
| format | Article |
| id | doaj.art-b65e78b531044213997dc3b2dee3b742 |
| institution | Directory Open Access Journal |
| issn | 1452-8258 1452-8266 |
| language | English |
| last_indexed | 2024-12-12T06:43:38Z |
| publishDate | 2009-01-01 |
| publisher | Society of Medical Biochemists of Serbia, Belgrade |
| record_format | Article |
| series | Journal of Medical Biochemistry |
| spelling | doaj.art-b65e78b531044213997dc3b2dee3b7422022-12-22T00:34:15ZengSociety of Medical Biochemists of Serbia, BelgradeJournal of Medical Biochemistry1452-82581452-82662009-01-012831451511452-82580903145EEvaluation of coronary risk score applications in 10-year coronary heart risk estimationEremić Nevena0Đerić Mirjana1Center for Laboratory Medicine, Clinical Center of Vojvodina, Novi SadCenter for Laboratory Medicine, Clinical Center of Vojvodina, Novi SadAtherosclerosis is a multifactorial disease with risk factors that have multiple effects. In the identification and treatment of asymptomatic individuals at high risk for developing coronary heart disease (CHD) different risk scoring schemes are used in everyday routine. The aim of this study was to compare SCORE recommended for our country with two other most frequently used risk schemes for 10-year CHD risk evaluation: Framingham and PROCAM as well as their modifications. From 220 examined subjects of both sexes, who were treated mainly for lipid metabolism disorder at the Dispensary for Atherosclerosis Prevention, Center for Laboratory Medicine, Clinical Center of Vojvodina, 110 subjects were included in our study and agreed to a one-year follow-up. At first check-up, 15% had low risk according to Framingham Weibull and 78% according to PROCAM, intermediate 12% according to PROCAM NS up to 45% according to Framingham Weibull, and high 8% according to PROCAM up to 40% according to Framingham Weibull. After a one-year treatment 30% were in the low risk category according to Framingham Weibull and 88% according to PROCAM. Intermediate from 10% according to PROCAM to 36% according to Framingham Weibull, and high from 2% according to PROCAM to 25% according to Framingham Weibull. There is a significantly lower percentage of high risk individuals and a higher percentage of low risk individuals after one year of lipid disorder treatment.https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2009/1452-82580903145E.pdfcoronary heart diseaserisk factorsrisk estimationhyperlipidemia |
| spellingShingle | Eremić Nevena Đerić Mirjana Evaluation of coronary risk score applications in 10-year coronary heart risk estimation Journal of Medical Biochemistry coronary heart disease risk factors risk estimation hyperlipidemia |
| title | Evaluation of coronary risk score applications in 10-year coronary heart risk estimation |
| title_full | Evaluation of coronary risk score applications in 10-year coronary heart risk estimation |
| title_fullStr | Evaluation of coronary risk score applications in 10-year coronary heart risk estimation |
| title_full_unstemmed | Evaluation of coronary risk score applications in 10-year coronary heart risk estimation |
| title_short | Evaluation of coronary risk score applications in 10-year coronary heart risk estimation |
| title_sort | evaluation of coronary risk score applications in 10 year coronary heart risk estimation |
| topic | coronary heart disease risk factors risk estimation hyperlipidemia |
| url | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2009/1452-82580903145E.pdf |
| work_keys_str_mv | AT eremicnevena evaluationofcoronaryriskscoreapplicationsin10yearcoronaryheartriskestimation AT đericmirjana evaluationofcoronaryriskscoreapplicationsin10yearcoronaryheartriskestimation |